NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Care Facilities · USD

The Oncology Institute, Inc. (STLN) Stock Analysis

The Oncology Institute, Inc. (STLN) is a Medical Care Facilities stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

STLN

$6.83

+$0.20 (+3.02%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare STLN with… →

STLN Key Statistics

As of Oct 21, 2026
Trading
Open
$6.67
Previous Close
$6.63
Day's Range
6.62–6.95
52-Week Range
2.32–7.13
Volume
1.45M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.42
Valuation
Market Cap
$696.09M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.19
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.29
Financials (FY)
Revenue (FY)
$502.73M+27.79%
Net Income (FY)
−$60.61M
Profit marginThe share of revenue left as profit after all costs and taxes.
−6.18%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
101.92M
Dividend and dates
Earnings Date
November 9, 2026
Avg Volume
1.38M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

The Oncology Institute, Inc. (STLN) has a market capitalization of $696.09M.

In fiscal 2025, STLN reported revenue of $502.73M.

STLN Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$502.73M−$60.61M−12.1%
2024$393.41M−$64.66M−16.4%
2023$324.24M−$83.07M−25.6%
2022$252.48M$152.00K0.1%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$502.73M$76.44M−$36.08M−$60.61M−12.1%
2024$393.41M$54.00M−$60.12M−$64.66M−16.4%
2023$324.24M$59.57M−$60.15M−$83.07M−25.6%
2022$252.48M$52.09M−$72.01M$152.00K0.1%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

STLN Valuation vs Medical Care Facilities Median

Median of 54 stocks
MetricSTLNMedical Care Facilities medianvs median
P/S ratio1.190.8736% above
Profit margin−6.18%3.19%9.4 pts below

Medians across 54 Medical Care Facilities stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The Oncology Institute, Inc. (STLN) carries a market capitalisation of $696.09M. It is classified in the Medical Care Facilities industry, within the Healthcare sector. The company reports 641 employees.

The 52-week range on file runs from $2.32 to $7.13. STLN last closed at $6.83 on October 21, 2026. That is +$0.20 (+3.02%) against the previous close. The latest close sits 194.4% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $502.73M. That is +27.79% against the prior fiscal year, when revenue was $393.41M. The same year closed with a net loss of $60.61M. Profit margin runs at −6.18%. That is 9.4 percentage points below the Medical Care Facilities median of 3.19%. Earnings per share on a trailing basis come to −0.29.

Across the 4 fiscal years on file, revenue moves from $252.48M in 2022 to $502.73M in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 1.19 times revenue. On price-to-sales that is 36.42% above the Medical Care Facilities median of 0.87. The medians here are taken across 54 Medical Care Facilities companies that report the metric.

The reported beta is 0.42.

Growth & Income

No dividend is on file for STLN.

So far in 2026 the total return is +31.60%.

Peer Comparison

The Oncology Institute, Inc. (STLN) operates in the Medical Care Facilities industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
The Oncology Institute, Inc. STLN $696.09M —
HCA Healthcare, Inc. HCA $99.46B 15.4
Tenet Healthcare Corporation THC $21.67B 10.6
Encompass Health Corporation EHC $11.88B 20.2

The Medical Care Facilities industry average P/E ratio is 20.7x. The Oncology Institute, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Care Facilities Stocks

HCA

HCA Healthcare, Inc.

$99.46B

 THC

Tenet Healthcare Corporation

$21.67B

 EHC

Encompass Health Corporation

$11.88B

 FMS

Fresenius Medical Care AG

$11.47B

 DVA

DaVita Inc.

$11.28B

 UHS

Universal Health Services, Inc.

$10.78B
View all Medical Care Facilities stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About The Oncology Institute, Inc.

Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The company was formerly known as The Oncology Institute, Inc. and changed its name to Starling Oncology, Inc. in August 2026. Starling Oncology, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Visit website →